The clinical utility of ANCA positivity

Annals of the Rheumatic Diseases

Volumn 55, Issue 8, 1996, Pages 494-496

  Edgar, J D M ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

AUTOIMMUNITY; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC VALUE; EDITORIAL; HUMAN; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS;

EID: 0029977735     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.8.494     Document Type: Editorial

References (37)

1. Ramirez G, Khamashta M A, Hughes G R V. The ANCA test: its clinical relevance. Ann Rheum Dis 1990; 49: 741-2.
2. Viik A. Delineation of a standard procedure for indirect immunofluorescent detection of ANCA. Acta Pathohgica Microbiologica Immtmologica Scandanavica 1989; 97 (suppl): 12-13.
3. Spicken G P, Broomhead V. Formalin fixation and patterns of antineutrophil cytoplasmic antibodies. J Clin Palhol 1995; 48: 89-90.
4. Segelmark Ai, Baslund B, Wjeslander J. Some patients with anti-myeloperoxidase autoantibodies have a c-ANCA pattern. Clin Exp Immmol 1994; 96: 458-65.
5. Baslund B, Segelmark M, Viik A, Szpirt V, Peterson J, Wieslander J. Screening for anti-neutrophil cytoplasmic antibodies (ANÇA): is indirect immunofluorescence the method of choice? Clin Exp Immunol 1995; 99: 486-92.
6. Hagen E C. Development and standardisation of solid-phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA) for clinical application: report of a large clinical evaluation study. Clin Exp Immunol 1995; 101 (suppl 1): 29.
7. Davies D J, Moran J E, Niall J F, Ryan G B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? BMJ 1982; 285: 606.
8. van der Woude F J, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's Granulomatosis. Lancet 1985; 1:425-9.
9. Jenette J C, Falk R J. Antineutrophil cytoplasmic auto-antibodies and associated diseases: a review. Am J Kidney Dis 1990; 15: 517-29.
10. Rump J A, Scholmerich J, Gross V, et al. A new tjpe of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 1990; 181:406-13.
11. Esnault V L M, Ronda N, Jayne D R V, Lockwood C M. Association of ANCA isotype and affinity with disease expression. J Ataoimmun 1993; 6: 197-205.
12. Nash M C, Shah V, Reader J A, Dillon M J. Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies are not increased in Kawasaki disease. Br J Rheumatol 1995; 34: 882-7.
13. Mains B. VTegener's granulomatosis: false positive anti-neutrophil cytoplasmic antibody test. J Laryngol Owl 1989; 103: 524-5.
14. Efthimou J, Spicken G, Lane D, Thompson A. Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection [letter]. Lancet 1991; 337: 1037-8.
15. Juby C, Johnston C, Davis P, Russell A S. Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol 1992; 31: 185-8.
16. Coremans I E M, Hagen E C, Daha M R, et al. Antilactoferrin antibodies in patients with arthritis are associated with vasculitis. Arthritis Rheum 1992; 35: 1466-75.
17. Schnabel A, Csernok E, Isenberg D A, Mrowka C, Gross W L. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus: prevalence, specificities and clinical significance. Arthritis Rheum 1995; 38: 633-7.
18. Targan S R, Landers C, Vidrich A, Czaja A J. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gasiroenterology 1995; 108: 1159-66.
19. Edgar J D M, Rooney D P, McNamee P, McNeill T A. An association between ANCA positive renal disease and malignancy. Clin Nephrol 1993; 40: 22-5.
20. Vecchio T J. Predictive value of a single diagnostic test in unselected populations. Lancet 1966; 274: 1171-3.
21. Davenport A, Lock R J, ValIington T B, Feest T G. Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardised indirect immunofluorescence assay. QJAIed 1994; 87: 291-9.
22. Edgar J D M, McMillan S A, Bruce I, Conlan S K. An audit of ANCA in routine clinical practice. Postgrad Aled J 1995; 71: 605-12.
23. Rao J K, Allen N B, Feussner J R, einberger M. A prospective study of antineutrophil cytoplasmic antibody (cANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 1995; 346: 926-31.
24. Leavitt R Y, Fauci A S, Bloch D A, et a!. The American College of Rheumatology 1990 criteria for the classification of VTegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
25. Tervaert J W C, Huitema M G, Hene R J, et al. Prevention of relapses in XVegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709-11.
26. Egner W, Chapel H M. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immtmol 1990; 82: 244-9.
27. Jayne D RV, Gaskin G, Pusey C D, Lockwood C M. ANCA and predicting relapse in systemic vasculitis. QJ tiled 1995; 88: 127-33.
28. Davenport A, Lock R J, Wallington T. Clinical significance of the serial measurement of autoantibodies to neutrophil cytoplasm using a standard indirect immunofluorescence test. AmJNephrol 1995; 15: 201-7.
29. Kerr G S, Fleisher T A, Hallahan C W, et al. Limited prognostic value of changes in anti-neutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36: 365-71.
30. Braun M G, Csemok E, Schmitt W, Hauschild S, Gross W L. Anti-neutrophil cytoplasmic antibodies (ANCA) and extra-articular involvement in rheumatoid arthritis (RA) [abstract]. Clin Exp Immunol 1993;93(suppl):33.
31. Falk R J, Terrell R S, Charles L A, Jennette J C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Nad Acad Sci 1990; 87: 4115-9.
32. Gross W L, Schmitt W H, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1-12.
33. Porges A J, Redecha P B, Kimberly V T, Csemok E, Gross VP L, Kimberly R P. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FcrRIIa. J Immunol 1994; 153: 1271-80.
34. Mulder A H L, Horst G, Limburg P C, Kallenberg C G M. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies is FcR-dependent. Clin Exp Immunol 1994; 98: 270-8.
35. Blank M, Tomer Y, Stein M, et al. Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces thé production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 1995; 102:120-30.
36. Luqmani R A, Bacon P A, Beaman M, et al. Classical versus non-renal Wegener's granulomatosis. QJAIed 1994; 84: 161-7.
37. Rose N R, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14: 426-30.